% IMPORTANT: The following is UTF-8 encoded.  This means that in the presence
% of non-ASCII characters, it will not work with BibTeX 0.99 or older.
% Instead, you should use an up-to-date BibTeX implementation like “bibtex8” or
% “biber”.

@ARTICLE{Poorebrahim:178838,
      author       = {M. Poorebrahim$^*$ and I. Quiros-Fernandez$^*$ and E.
                      Fakhr$^*$ and A. Cid-Arregui$^*$},
      title        = {{G}eneration of {CAR}-{T} cells using lentiviral vectors.},
      journal      = {Methods in cell biology},
      volume       = {167},
      issn         = {0091-679x},
      address      = {New York, NY [u.a.]},
      publisher    = {Elsevier},
      reportid     = {DKFZ-2022-00301},
      pages        = {39-69},
      year         = {2022},
      note         = {#EA:D122#LA:D122#},
      abstract     = {Cancer immunotherapy is nowadays largely focused on the
                      development of therapeutic antibodies and chimeric antigen
                      receptors (CARs). Two CARs targeting CD19 have been approved
                      recently for the treatment of some hematological
                      malignancies. This demonstrates the capability of engineered
                      CAR T cells in generating effective tumor responses.
                      Furthermore, several hundred ongoing clinical trials are
                      exploring the feasibility of CAR-based approaches to target
                      tumor-associated antigens in solid tumors. However, there
                      still remain significant challenges and limitations in the
                      design and production of CAR-modified T cells that need to
                      be addressed, such as more effective transduction methods,
                      expression and exhaustion issues, reliable in vitro and in
                      vivo characterization methods, etc. Here we describe current
                      techniques for generating CAR T cells using lentiviral
                      vectors as well as detailed protocols for their functional
                      characterization.},
      keywords     = {CAR-T (Other) / Cell avidity analysis (Other) / Chimeric
                      antigen receptor (CAR) (Other) / Electroporation (Other) /
                      Jurkat (Other) / Lentiviral vector (Other) / PBMC (Other) /
                      Transposon system (Other)},
      cin          = {D122},
      ddc          = {570},
      cid          = {I:(DE-He78)D122-20160331},
      pnm          = {314 - Immunologie und Krebs (POF4-314)},
      pid          = {G:(DE-HGF)POF4-314},
      typ          = {PUB:(DE-HGF)16},
      pubmed       = {pmid:35152998},
      doi          = {10.1016/bs.mcb.2021.07.001},
      url          = {https://inrepo02.dkfz.de/record/178838},
}